Navidea Biopharmaceuticals Files for Bankruptcy in Delaware

Navidea Biopharmaceuticals filed for a voluntary petition for relief under Chapter 11 in the US Bankruptcy Court for the District of Delaware on Oct 1.

• Intends to enable orderly restructuring of its financial obligations while continuing limited operations

To view the source of this information, click here

To contact the reporter on this story:
Andrew Mendez in San Francisco at amendez112@bloomberg.net

To contact the editors responsible for this story:
Zachary Fleming at zfleming2@bloomberg.net

Dale Quinn

© 2025 Bloomberg L.P. All rights reserved. Used with permission.